FDA OKs emergency use of Baxter blood filter for COVID-19

The FDA has signed off on emergency use of Baxter International’s (BAX +1.2%) Oxiris purification device for COVID-19 patients with confirmed or imminent respiratory failure who need pro-inflammatory cytokines removed from their blood, including use in continuous renal replacement therapy.

The company says a small number of devices will be available immediately with more significant production ramping up in the coming weeks and months.

https://seekingalpha.com/news/3563843-fda-oks-emergency-use-of-baxter-blood-filter-for-covidminus-19